In collaboration with the United Kingdom's National Health Service (NHS), four ophthalmologists are beginning a large 1,000 patient multi-center study to assess the overall prevalence of Dry Eye Disease ("DED").
Patients who suffer from a wide variety of eye complications presenting daily in NHS clinics will be the primary target group of this study. Tear osmolarity testing will be incorporated as a diagnostic measure to detect the presence of DED. The study will be conducted under ethical controls, adopted by the National Institute of Health Research in the UK and will allow UK ophthalmologists to view DED in their own patient base.
"This is a unique opportunity to truly assess the prevalence of DED in a large patient population utilizing objective data, now available to us through osmolarity testing," commented Miss Francesca Harman, THH, a highly experienced NHS Consultant Ophthalmologist from the London area who will be leading the study.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in